← Eichor
Study identifier: NCT05237232 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children

Condition: Extra Corporeal Membrane Oxygenation · Decanulated Alive  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants30
Who can joinAll sexes, N/A to 17 Years
Healthy volunteersNo

About this study

Extra corporeal membrane oxygenation (ECMO) is a transient supplementation technique that alleviates hemodynamic and ventilatory failure. Its implementation requires carotid arterial and jugular venous cannulation in newborns or children weighing less than 20 kg. The impact of ECMO on arterial circulation was studied by Doppler ultrasound and shows a redistribution of flows within the circle of Willis. This study aims to model cerebral flow in children who have been cared from jugulocarotid ECMO and compare cerebral hemodynamics according to the technique of reconstruction of the common carotid artery after decanulation (reconstruction or ligation).

This description comes directly from the study's public registry record.

Talk to the study team

Sabine Irtan, MD, PhD  ·  1 71 73 87 98  ·  sabine.irtan@aphp.fr

Hélène Morel  ·  1 71 19 63 46  ·  helene.morel@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital TrousseauParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05237232